• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number 5MAXACE132
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intracranial Hemorrhage (1891); Neurological Deficit/Dysfunction (1982); Paralysis (1997)
Event Date 11/15/2016
Event Type  Injury  
Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Potential adverse events with the use of the penumbra system 5max ace reperfusion catheter (5max ace) include hemorrhage and neurological deficits and are included in the labeling.Therefore, it was determined that the reported intracranial hemorrhage and aphasia were potential complications related to the use of the 5max ace.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.The hospital disposed of the device.
 
Event Description
On (b)(6) 2016, the patient underwent a thrombectomy procedure to treat an acute-stage cerebral infarction using a penumbra system 5max ace reperfusion catheter (5maxace) and a non-penumbra stent retriever device.Fifteen hours after the procedure, a hemorrhagic transformation (ph2 level) occurred at the occlusion site.It is unknown whether or not additional treatment was performed after the original procedure, due to insufficient information.The intracranial bleeding was determined to have a probable relationship with the 5maxace.On (b)(6) 2016, the patient also suffered paralysis on the right side of the body and was confirmed to have aphasia.On (b)(6) 2016, the patient was transferred to another hospital.On (b)(6) 2016, the patient expired due to deteriorated general condition.The patient''s death was determined to be unrelated to the 5maxace.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key7127738
MDR Text Key95170485
Report Number3005168196-2017-02237
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00814548012803
UDI-Public00814548012803
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K160449
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date07/01/2019
Device Catalogue Number5MAXACE132
Device Lot NumberF70411
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/22/2017
Initial Date FDA Received12/18/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2016
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other;
Patient Age70 YR
Patient Weight46
-
-